NEW YORK--(BUSINESS WIRE)--ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that the Company is scheduled to present at the Bank of America 2008 Healthcare Conference in Las Vegas on Thursday, May 15, 2008 at 10:30 a.m. PDT. A corporate overview will be provided, including additional information on the Company’s product portfolio.
